Navigation Links
truDERMA ® Welcomes CFO Bryan O’Connell
Date:5/16/2013

Las Vegas, Nevada (PRWEB) May 16, 2013

truDERMA (http://www.truderma.com), the top selling nutraceutical manufacturer of popular weight-loss supplements Mangodrin and Troxyphen, today announced that Bryan O’Connell has been appointed Chief Financial Officer.

Prior to joining truDERMA, O’Connell spent time in several different industries as CFO for both domestic and international companies. He worked with businesses during their growth phase implementing systems that allowed growth to upwards of $500 million in annual sales. His responsibilities included preparation of the company’s financial information, overseeing financial and IT staff, coordinating and managing budgeting processes, and active participation in the development of the company’s outlook and strategy.

“We are delighted Bryan is joining the truDERMA team,” said Michael Gardineer, truDERMA CEO “His strength and breadth of experience will be invaluable as we define the future of truDERMA and expand from our start-up roots to a leader in the nutraceutical industry.”

As CFO of truDERMA, O’Connell will be responsible for global oversight and management of corporate financial strategy to help the company achieve its business objectives and continue expanding its operations domestically and internationally.

“Creating value through both organic growth and operations is the key to helping companies successfully scale, and truDERMA is one of the fastest growing companies in the nutraceutical space,” said Bryan O’Connell, truDERMA CFO. “I look forward to building upon the success and continuing to help drive innovation, growth, and results for truDERMA.”

O’Connell holds a bachelor’s degree in accounting and a master’s degree in business administration from the University of Nevada Las Vegas. Outside of work he enjoys spending time with his wife and their two children.

About truDERMA
Based in Las Vegas, Nev., truDERMA (http://www.truderma.com) is a company focused on solving specific problems. The company researches the best formulations, ingredients, trends and suppliers to help customers reach their personal goals. In particular, the company helps men and women reach their weight loss goals. The company offers Mangodrin, Mangodrin SF, Troxyphen, DermaSLIM, UTRIM, and Adrenal Support. The management team and staff of truDERMA are passionate about healthy living and helping others achieve life-changing goals. The company stands by its products and provides a 100 percent money-back guarantee for product satisfaction to consumers.

EDITOR’S NOTE: To speak with truDERMA’s CEO, Michael Gardineer, or for more information about truDERMA, please contact L. Consoli at 702.321.1624 or pr(at)truderma(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10728819.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. truDERMA™ Launches Troxyphen, Breakthrough Weight Loss Supplement for Men
2. truDERMA™ Exhibiting at the Beautiful Bride Expo – Booth 103
3. truDERMA™ Expands Into New Headquarters
4. 5-hour ENERGY® Launches Fitspiration Pinterest Sweepstakes
5. Long-Time-Liner® Beverly Hills Reports on Today’s Eyebrow Runway Make-Up Trends
6. PBS Archives SAP® with KOMpliance
7. Charm Sciences Announces Six WET® (Water Extraction Technology) Mycotoxin Tests
8. Sklar Joins docBeat®'s High-Profile Board of Directors as General Counsel and Secretary of the Board
9. SENSA® Weight-Loss System Now Available at Defense Commissary Agency Locations Nationwide
10. Plastic Oddities® Announces New Product on Kickstarter – the Cleanout Plug Puller Tool™
11. Special Promotion Friday through Sunday Only: Buy One Sublime Beauty® Skin Brush and Get One for a Family Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and ... the ultimate weight loss and wellness program, at their world headquarters of Omni La ... immediate and long-term results to anyone seeking weight loss, personal development, a healthy lifestyle, ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... continuity to its innovative Unified Instance Manager architecture, meeting the needs of ... new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, provides ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Care Act. Dr. Botelho advocates for the mass media launching of story movements ... ongoing opportunities to share their unfortunate experiences; such a movement can generate the ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... 2016 Research and Markets has announced the addition ... to their offering. ... The report provides separate comprehensive analytics for ... and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:12/7/2016)... -- "Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight" report by ... drug in clinical pipeline. Currently 5 biosimilar version of Lantus are commercially ... Kenya , Czech Republic , ... , Slovakia , United Kingdom ... patent on Lantus expired in 2014. Lantus is the brand name ...
Breaking Medicine Technology: